MARKET

LCI

LCI

Lannett Co
NYSE

Real-time Quotes | Nasdaq Last Sale

4.810
+0.030
+0.63%
Pre Market: 5.32 +0.51 +10.60% 05:02 06/17 EDT
OPEN
4.850
PREV CLOSE
4.780
HIGH
4.920
LOW
4.745
VOLUME
2.74K
TURNOVER
--
52 WEEK HIGH
10.70
52 WEEK LOW
4.120
MARKET CAP
199.36M
P/E (TTM)
-0.9704
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Benzinga · 11h ago
Roth Capital Maintains Neutral on Lannett, Lowers Price Target to $7
Roth Capital analyst Scott Henry maintains Lannett (NYSE:LCI) with a Neutral and lowers the price target from $7.5 to $7.
Benzinga · 6d ago
--Roth Capital Adjusts Lannett PT to $7 From $7.50, Maintains Neutral Rating
MT Newswires · 6d ago
75 Biggest Movers From Yesterday
Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares surged 85.8% to close at $22.15 on Tuesday amid increased retail investor interest in the stock.
Benzinga · 06/09 09:01
Lannett (LCI) Soars 10.1%: Is Further Upside Left in the Stock?
Lannett (LCI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks · 06/09 07:25
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
Benzinga · 06/07 21:49
Lannett Co Stock Is Estimated To Be Modestly Undervalued
GuruFocus News · 06/05 15:00
46 Stocks Moving In Thursday's Mid-Day Session
Gainers GTT Communications, Inc. (NYSE: GTT) shares jumped 66% to $4.16 on abnormally-high volume. The company’s stock also jumped over 57% on Wednesday.
Benzinga · 06/03 16:09
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LCI. Analyze the recent business situations of Lannett Co through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LCI stock price target is 5.75 with a high estimate of 7.00 and a low estimate of 5.00.
EPS
Institutional Holdings
Institutions: 215
Institutional Holdings: 40.64M
% Owned: 98.06%
Shares Outstanding: 41.45M
TypeInstitutionsShares
Increased
30
1.27M
New
17
495.19K
Decreased
47
2.03M
Sold Out
15
306.60K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.39%
Pharmaceuticals & Medical Research
-0.46%
Key Executives
Chairman/Independent Director
Patrick LePore
Chief Executive Officer/Director
Timothy Crew
Chief Financial Officer/Chief Accounting Officer/Vice President - Finance
John Kozlowski
Chief Operating Officer/Vice President
John Abt
Senior Vice President
Maureen Cavanaugh
Vice President/Chief Information Officer
Robert Ehlinger
General Counsel
Samuel Israel
Director
Jeffrey Farber
Independent Director
John Chapman
Independent Director
David Drabik
Independent Director
Melissa Rewolinski
Independent Director
Paul Taveira
No Data
About LCI
Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June 30, 2016, the Company's products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules. The Company has additional products under development, which are orally administered solid oral-dosage products (tablet/capsule) or oral solutions, nasal, topicals or parentarels, as well as other dosage forms.

Webull offers kinds of Lannett Company, Inc. stock information, including NYSE:LCI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LCI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LCI stock methods without spending real money on the virtual paper trading platform.